Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

ion with drugs that have ulcerogenic or hemorrhagic potential, such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, oral bisphosphonates or anticoagulants.

The most frequently occurring adverse reactions with a suspected relationship to Exjade were diarrhea, vomiting, nausea, abdominal pain, skin rash and increases in serum creatinine. Maintenance of adequate hydration for patients experiencing diarrhea or vomiting is recommended. Gastrointestinal symptoms, increases in serum creatinine and skin rash were dose related. These commonly reported adverse events were predominantly mild to moderate in severity with serious adverse events reported in 9.1% of patients in the Exjade arm and 8.6% of patients in the deferoxamine arm.

For full prescribing information, please visit www.us.exjade.com.

About Femara

Femara(R) (letrozole tablets) is approved for the adjuvant (following surgery) treatment of postmenopausal women with hormone receptor-positive early stage breast cancer. The benefits of Femara in clinical trials are based on 24 months of treatment. Further follow-up will be needed to determine long-term results, safety and efficacy.

Femara is also approved for the extended adjuvant treatment of early stage breast cancer in postmenopausal women who are within three months of completion of five years of tamoxifen therapy. The benefits of Femara in clinical trial are based on 24 months of treatment. Further follow-up will be needed to determine long-term results, including side effects.

In addition, Femara is approved for the treatment of postmenopausal women with estrogen receptor-positive or estrogen receptor-unknown breast cancer that has spread to another part of the body (metastatic cancer).

You should not take Femara if you are premenopausal. Your doct
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... December 17 ,Agendia, a world leader in ... and Drug Administration (FDA) cleared its MammaPrint breast,cancer ... only FDA-cleared,breast cancer recurrence test available to patients ... has issued four clearances for MammaPrint, covering,all aspects ... "This FDA clearance, along with our recently ...
(Date:12/17/2009)... SAN DIEGO, Dec. 17 Suneva Medical, ... that it has signed a multi-million dollar line ... The line of credit facility will be ... only FDA-approved microsphere-enhanced collagen dermal filler on the ... Aesthetic Market growth objectives. ,, "Today Suneva Medical ...
(Date:12/17/2009)... 17 Instacare Corp. (OTC Bulletin Board: ... life-enhancing prescription drugs and diagnostics and at home ... leading developer and provider of e-health technologies and ... today that as part of the preparation of ... to add two new Directors and has rejected, ...
Breaking Medicine Technology:FDA Broadens Clearance for Agendia's MammaPrint(R) 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 3Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Normal cells far from cancer give nanosignals of trouble 9146 1Normal cells far from cancer give nanosignals of trouble 9146 2Normal cells far from cancer give nanosignals of trouble 9146 3Playing it safe 9143 1Claimsnet Announces Claims Processing Agreement With New Health Care Solutions Company 50956 1Claimsnet Announces Claims Processing Agreement With New Health Care Solutions Company 50956 2
(Date:12/17/2009)... arms and legs in order to correct limb deformities, repair traumatic ... patients can remain mobile while growing new bone, resulting in fewer ... ... December 17, 2009 -- Dr. Randolph C. Robinson , a ... in Lone Tree, Colorado, has been granted a U.S. patent ...
(Date:12/17/2009)... facial aesthetics specialist offers a discount certificate to introduce the wonders ... ... December 17, 2009 -- Jeffrey R. Raval, MD, FACS, a Denver ... Mountain Laser Aesthetics in Cherry Creek North, is offering an online ... Gift Certificate for $100 in services or products for just $75., ...
(Date:12/17/2009)... 17 Pacific Shore Holdings, ... balms, today announced the launch of their new ... treatment packs are specifically designed to reduce swelling ... a variety of applications. Researchers behind Thermal-Aid created ... corn to hold temperatures for long periods of ...
(Date:12/17/2009)... 30-Year Lease Agreement Will Help Stevens Hospital Expand, ... ,, EDMONDS, Wash., Dec. 17 The ... of Snohomish County today approved non-binding terms for ... Hospital to be effective this summer, pending regulatory ... to a hearing in mid-January to learn more ...
(Date:12/17/2009)... -- and adding to obesity epidemic, study says , , THURSDAY, ... for a new sofa, don,t despair: 22 percent of U.S. ... report finds. , In fact, the sale of high-calorie snack ... segments of the retail market, say the authors of the ... of Public Health . The easy availability of snack ...
Breaking Medicine News(10 mins):Health News:Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow 2Health News:Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow 3Health News:Holiday Aesthetics Special is Ageless Beauty Gift from Denver's Dr. Raval 2Health News:Holiday Aesthetics Special is Ageless Beauty Gift from Denver's Dr. Raval 3Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Stevens Hospital to Affiliate with Swedish 2Health News:Stevens Hospital to Affiliate with Swedish 3Health News:Stevens Hospital to Affiliate with Swedish 4Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2
... of the only tuberculosis vaccine approved for humans provided ... test, report scientists at The University of Texas Health ... Advance Online Publication March 1. Their findings resulted from ... National Institutes of Health (NIH). , Bacille Calmette-Gurin ...
... Calif., March 3 /PRNewswire/ -- ... that it is expanding the states in which ... the country,s largest private provider of emergency neurology ... than 5,500 emergency neurology consultations to date.(Logo: ...
... The Libyan Department of Relief and Humanitarian ... a significant capability for medical disaster response in ... experts from the American-based company BLU-MED Response Systems ... University where members of Libyan Aid erected the ...
... soles of their feet and the palms of their hands ... some types of chemotherapy. Patients, family members also can feel ... Both share a need for quick answers or more detailed ... or unexpected symptoms. , A new section of the ...
... (OTC Bulletin Board: PLCSF) announced today that it expects to ... fourth quarter and year ended December 31, 2008 before the ... to host a conference call to discuss those results at ... be joined via telephone by dialing (866) 356-3377 or (617) ...
... Her Quest to Raise One Million Dollars for Charity, Makes ... March 3 At 56, Linda Quirk has undergone an ... under a year. She began her trek across the ... has since gone on to run the Great Wall of ...
Other Medicine News:Health News:TB breakthrough could lead to stronger vaccine 2Health News:TB breakthrough could lead to stronger vaccine 3Health News:Specialists On Call Expands Access to Emergency Neurology On-Call Services in Montana 2Health News:Libyan Aid Tests 50-Bed BLU-MED Deployable Field Hospital 2Health News:Walther Cancer Foundation grant funds new IU Simon Cancer Center Web site section 2Health News:56-Year-Old Grandmother Heads to Antarctica to Run Her Seventh Worldwide Marathon in Under a Year 2Health News:56-Year-Old Grandmother Heads to Antarctica to Run Her Seventh Worldwide Marathon in Under a Year 3
... immunoassay system built around the many positive ... important addition of Logic Driven Incubation (LDI). ... for optimal performance with the fastest possible ... such as the cardiac biomarkers and HCG ...
... For The Detection ... Uses Of C-Peptide Measurement:, ... fasting hypoglycemia , Assisting ... diabetes mellitus , Differentiating ...
... for the quantitative determination of C-peptide in ... Automatic Immunoassay System. C-peptide measurement is used ... patients treated with insulin, to distinguish between ... various other diagnostic applications in patients with ...
... Multifocal IOL was designed to provide a ... glasses in most situations. While distance vision ... to that of a single vision monofocal ... and about 19 in 20 people with ...
Medicine Products: